Association between hepatitis C infection and other infectious diseases: A case for targeted screening?

American Journal of Gastroenterology

Volumn 98, Issue 1, 2003, Pages 167-174

  El Serag, Hashem B ^a,b   Anand, Bhupinderjit ^a   Richardson, Peter ^a   Rabeneck, Linda ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANALYSIS; ARTICLE; AUTOMATION; CARBUNCLE; CASE CONTROL STUDY; CELLULITIS; CHLAMYDIASIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DATA BASE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENDOCARDITIS; ETHNOLOGY; FEMALE; GENITAL HERPES; GONORRHEA; GOVERNMENT; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; ORGAN TRANSPLANTATION; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SEPSIS; SYPHILIS; TOXOPLASMOSIS; TREATMENT INDICATION; TUBERCULOSIS; VIET NAM;

CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HUMANS; INFECTION; MALE; MASS SCREENING; MIDDLE AGED;

EID: 0037260153     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07176.x     Document Type: Article

References (26)

1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:446-52.
2. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000;95:740-7.
3. Kizer KW. Under Secretary for Health, U.S. Department of Veterans Affairs, Testimony before U.S. Senate Committee on Appropriations, Subcommittee on Veterans Affairs. Washington, DC: U.S. Government Printing Office, 1999.
4. Alter MJ, Hutin YJF, Armstrong GL. Epidemiology of hepatitis C. In: Liang TK, Hoofnagle JH, eds. Hepatitis C. Academic Press, 2000:169-83.
5. Seeff LB. The natural history of chronic hepatitis C infection. Clin Liver Dis 1997;1:857-62.
6. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984;4:53-8.
7. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986;6:252-62.
8. Garcia-Gonzalez, Boixeda D, Herrero D, Burgaleta C. Effect of granulocyte-macrophage colony-stimulating factor on leucocyte function in cirrhosis. Gastroenterology 1993;105:527-31.
9. Rabinovitz M, Gavaler JS, Kumar S, et al. Role of serum complement, immunoglobulins, and cell-mediated immune system in the pathogenesis of spontaneous bacterial peritonitis (SBP). Dig Dis Sci 1989;34:1547-52.
10. Navasa M, Rimola A, Rodes J. Bacterial infections in liver disease. Semin Liver Dis 1997;17:323-33.
11. Balasekaran R, Bulterys M, Jamal MM, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999;94:1341-6.
12. LaQualia MP, Tolkoff-Rubin NE, Dienstag JL, et al. Impact of hepatitis on renal transplantation. Transplantation 1981;32:504-7.
13. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45:238-44.
14. Singh N, Gayowski T, Wagener MM, Mario IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996;61:402-6.
15. Boyko EJ, Koepsell TD, Gaziano JM, et al. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol 2000;151:307-14.
16. World Health Organization. The international classification of diseases, 9th revision. Clinical modification. 3rd ed. DHHS Publication No. (PHS) 89-1260, Washington, DC: Public Health Service, U.S. Government Printing Office, March 1989.
17. Kaplan JE, Masur H, Jaffe HW, Holmes KK. Preventing opportunistic infections in persons infected with HIV: 1997 guidelines. JAMA 1997;278:337-8.
18. SAS Institute Inc. SAS/STAT software. Changes and enhancements, release 6.10. Cary, NC: SAS Institute Inc, 1994:85.
19. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001;91:31-7.
20. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001;91:23-30.
21. Carey MP, Carey KB, Kalichman SC. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev 1997;17:271-91.
22. Zignego AL, De Carli M, Monti M, et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 1995; 47:58-64.
23. Henin C, Makris M, Brown J, et al. Peripheral mononuclear cells of hemophiliacs with chronic liver disease are infected with replicating hepatitis C virus. Br J Haematol 1994;87:215-7.
24. Ozyilkan E, Tatar G, Hacibertasoglu A, et al. Analysis of T-helper and T-suppressor lymphocyte subsets in patients with chronic hepatitis C virus infection. J Intem Med 1993;234:436-7.
25. Lloyd SS, Rissing JP. Physician and coding errors in patient records. JAMA 1985;254:1330-6.
26. Kashner TM. Agreement between administrative files and written medical records. A case of the Department of Veterans Affairs. Med Care 1998;36:1324-36.